Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
66.7%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed267%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Clinical Trial Tobacco Marijuana

NCT02277665
terminatednot_applicable

Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD

NCT02012452
completednot_applicable

Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations

NCT01156610

Clinical Trials (3)

Showing 3 of 3 trials
NCT02277665Not Applicable

Clinical Trial Tobacco Marijuana

Completed
NCT02012452Not Applicable

Tobacco Treatment as Augmentation for Cognitive Processing Therapy for PTSD

Terminated
NCT01156610Not Applicable

Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations

Completed

All 3 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
3